Iain Chalmers, Founding Director UK Cochrane Centre, The James Lind Library, United Kingdom

Michael Conlon, University of Florida Health Science Centre, USA

Victor DeGruttola, Professor of Biostatistics, Harvard School of Public Health, USA

Richard Horton, Editor, the Lancet, London, UK

Johan Karlberg, Director, Clinical Trials Centre, University of Hong Kong

Jeffrey Klofft, Phase Forward Incorporated, USA

Peter Shaw, Director, Human Genetics and Pharmacogenomics, Bristol Myers Squibb, USA

Bob Temple, Director, Office of Medical Policy, FDA, USA

Harvey White, Director, Cardiology Dept, Green Lane Hospital, Auckland, New Zealand

Hilda Bastian, Cochrane Consumer Network, Canberra

Stephen Blamey, Waverley Endoscopy Centre, Melbourne, Australia and Department of Health and Ageing, Canberra

Kerry Breen, Australian Health Ethics Committee, St Vincent’s Hospital, Melbourne

Peter Cashman, Maurice Blackburn Cashman, Sydney

David Celermajer, Department of Medicine, University of Sydney

Pam Clapshaw, South Eastern Sydney–Southern Sector Ethics Committee, Sydney
Chris Del Mar, Centre for General Practice, University of Queensland, Brisbane

Tim Dobbins, Department of Public Health and Community Medicine, University of Sydney, Sydney

Sally Galbraith, School of Mathematics, University of New South Wales, Sydney

Davina Ghersi, NHMRC Clinical Trials Centre, University of Sydney, Sydney

Paul Glasziou, Department of Social and Preventive Medicine, University of Queensland, Brisbane

David Henry, School of Population Health, University of Newcastle, Newcastle

Malcolm Hudson, Department of Statistics, Macqarie University, Sydney

Les Irwig, Department of Public Health and Community Medicine, University of Sydney, Sydney

Tony Keech, NHMRC Clinical Trials Centre, University of Sydney, Sydney

Bill Ketelby, Pfizer, Sydney

Sue Lockwood, Breast Cancer Action Group, Melbourne

George Morstyn, Melbourne

Bruce Neal, Institute for International Health, University of Sydney, Sydney

Terry Nolan, Department of Public Health and Community Medicine, University of Sydney, Sydney

Robyn Norton, Institute for International Health, University of Sydney, Sydney

Helen Ormandy, AstraZeneca Pty Ltd, Sydney

Lior Rauchberger, Medseed Pty Ltd, Melbourne

Sally Redman, Institute for Health Research, University of Sydney, Sydney

Judy Simpson, Department of Public Health and Community Medicine, University of Sydney, Sydney

Terry Speed, Walter and Eliza Hall Institute, Melbourne

Bruce Shadbolt, Centre for Advances in Epidemiology, Canberra

John Simes, NHMRC Clinical Trials Centre, University of Sydney, Sydney

Martin Tattersall, Department of Medicine, University of Sydney, Sydney

Colin Thomson, Faculty of Law, University of Wollongong, Wollongong

Ron Trent, Department of Medicine, University of Sydney, Sydney

Paul Vlagsma, NHMRC Clinical Trials Centre, University of Sydney, Sydney